Merck (MRK) Revenue and Net Income History
Historical revenue, operating income and net income for Merck (MRK) over the last 10 years. The current TTM revenue for Merck as of February 16, 2018 is $40.12B.
|Medical||Large Cap Pharmaceutical||$153.359B||$40.122B|
|Merck & Co., Inc., a leading global biopharmaceutical company known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. Through their prescription medicines, vaccines, biologic therapies and animal health products, they work with customers and operate the countries to deliver innovative health solutions. The Company also demonstrate their commitment to increasing access to health care through far-reaching policies, programs and partnerships. Merck continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer's disease and infectious diseases including HIV and Ebola.|